An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide .

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
This study will be an open-label study to evaluate the effect of albiglutide on the pharmacokinetics and pharmacodynamics of a standard oral contraceptive regimen (Brevicon). The primary objective of this study is to demonstrate the lack of effect of albiglutide doses on the pharmacokinetics of norethindrone and ethinyl estradiol in healthy female subjects.
Epistemonikos ID: 5e83eb97a5d9fd2cf53e11a933dbc9b4f0b49995
First added on: May 05, 2024